期刊文献+

1例肺癌合并静脉血栓栓塞的抗凝治疗分析 被引量:1

Anticoagulant Therapy in a Case of Lung Cancer Complicated with Venous Thromboembolism
下载PDF
导出
摘要 目的为恶性肿瘤合并静脉血栓栓塞使用利伐沙班进行抗凝治疗提供参考。方法回顾性分析1例外院使用那曲肝素钙治肺癌合并静脉血栓栓塞患者的临床资料,包括血小板减少情况、诊疗过程、抗凝治疗方案和治疗结果。结果采用利伐沙班抗凝及升血小板药物治疗后,血小板恢复正常,静脉栓塞症状好转。结论利伐沙班可作为肿瘤合并静脉血栓栓塞的抗凝治疗。 Objective To provide reference for the use of rivaroxaban in anticoagulant therapy for patients with malignant tumor complicated with venous thromboembolism. Methods The clinical data including thrombocytopenia,diagnosis and treatment process,anticoagulant therapy plan and treatment result of a patient with lung cancer complicated with venous thromboembolism treated with nadroparin calcium in an another hospital were analyzed retrospectively. Results After the patient received rivaroxaban anticoagulation and platelet elevation therapy,the platelets returned to normal and the symptoms of venous thromboembolism improved. Conclusion Rivaroxaban can be used as an anticoagulant therapy for patients with tumors complicated with venous thromboembolism.
作者 鲍蕾蕾 曹爱霖 李莹 王占坤 钱皎 BAO Leilei;CAO Ailin;LI Ying;WANG Zhankun;QIAN Jiao(Department of Medicinal Materials,Changhai Hospital of the Second Military Medical University,Shanghai,China 200433)
出处 《中国药业》 CAS 2019年第21期77-79,共3页 China Pharmaceuticals
关键词 血小板减少 那曲肝素钙 利伐沙班 抗凝 静脉血栓栓塞 合理用药 thrombocytopenia nadroparin calcium rivaroxaban anticoagulation venous thromboembolism rational drug use
  • 相关文献

参考文献4

二级参考文献57

  • 1邹望远,郭曲练,蔡进,罗和国.乌司他丁对骨科病人血小板聚集及凝血功能的影响[J].中南大学学报(医学版),2004,29(5):569-571. 被引量:15
  • 2国家"十五"攻关"肺栓塞规范化诊治方法的研究"课题组,杨媛华,翟振国,武燕兵,王辰.急性肺血栓栓塞症患者516例临床表现分析[J].中华医学杂志,2006,86(31):2161-2165. 被引量:79
  • 3陈蕾,张晓峰,丁慧苹,徐美英.全麻联合硬膜外阻滞对肺癌手术患者凝血与血小板功能的影响[J].临床麻醉学杂志,2006,22(9):708-709. 被引量:5
  • 4陆芸,马宝通,郭若霖,张建国,吴英华,庞贵根,辛景义,叶伟胜,邹玉安,王毅,董强,王学谦,Kerry H,Paul C,John F.骨科创伤患者深静脉血栓危险因素的研究[J].中华骨科杂志,2007,27(9):693-698. 被引量:244
  • 5Loreto MF, De Martinis M, Corsi MP, et al. Coagulation and cancer:impli- cation for diagnosis and management[J]. Pathol Oncol Res, 2000, 6: 301 - 312.
  • 6Lnoue K, Takano H, Sato H, et al. Protective role of urinary trypsin in- hibitor in lung expression of proinflammatory eytokines accompanied by lethal liver injury in mice[J] . Immunopharmacol Immunotoxicol, 2009, 31:446 - 450.
  • 7Linkins LA, Darts AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed :American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [ J ]. Chest, 2012, 141(2 Suppl) : 495-530.
  • 8Cuker A, Cines DB. How I treat heparin-induced thrembocytope- nia[J]. Blood, 2012, 119(10) :2209-2218.
  • 9Kasthuri RS, Glover SL, Jonas W, et al. PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive micmparticles by activation of FcγRI [ J ]. Blood, 2012, 119(22) :5285-5293.
  • 10Zhou A, Winkler A, Emamifar A, et al. Is the incidence of heparin- induced thrombocytopenia affected by the increased use of heparin for VIE prohpylaxis? [J]. Chest, 2012, 142(5) :1175-1178.

共引文献1029

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部